However, in the time-independent study, a significant increase of tumour CD4+ T cells and increased expression levels of CD44 marker on these cells were observed in nsECT4-treated compared to untreated tumour-bearing mice (Figure 6A). The gene discussed is CD44; the disease is neoplasm.